Quest Diagnostics Share Price Today
(NASDAQ: DGX)

Name: Quest Diagnostics Share Price Today (NASDAQ: DGX) - Quest Diagnostics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Quest Diagnostics share price is $178.22 & ₹15,093.01 as on 1 May 2025, 2.30 'hrs' IST

$178.22

▲

-0.28

(-0.16%)

Market is closed - opens 7 PM, 01 May 2025

View live Quest Diagnostics share price in Dollar and Rupees. Guide to invest in Quest Diagnostics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Quest Diagnostics, along with analyst recommendations, forecasts, and comprehensive financials.

Quest Diagnostics share price movements

Today's Low: $174.90
Today's High: $179.00
$178.22
1.87%
Downside
Day's Volatility :2.29%
Upside
0.44%
52 Weeks Low: $135.27
52 Weeks High: $179.00
$178.22
24.1%
Downside
52 Weeks Volatility :24.43%
Upside
0.44%

Quest Diagnostics (DGX) Returns

Period	Quest Diagnostics Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	8.78%	-5.2%	0.0%
6 Months	15.34%	-5.7%	0.0%
1 Year	29.83%	-0.9%	0.0%
3 Years	34.86%	6.9%	-5.1%

Quest Diagnostics (DGX) Key Statistics

in dollars & INR

Previous Close	$178.5
Open	$177.81
Today's High	$179.0
Today's Low	$174.895
Market Capitalization	$20.0B
Today's Volume	$1.3M
52 Week High	$179.0
52 Week Low	$135.265
Revenue TTM	$10.2B
EBITDA	$2.0B
Earnings Per Share (EPS)	$7.91
PE Ratio	22.34
Dividend Yield	1.84%
Profit Margin	8.83%
Quarterly Earnings Growth YOY	0.13%
Return On Equity TTM	13.95%

How to invest in Quest Diagnostics Stock (DGX) from India?

It is very easy for Indian residents to invest directly in Quest Diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Quest Diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Quest Diagnostics or DGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Quest Diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Quest Diagnostics shares which would translate to 0.005 fractional shares of Quest Diagnostics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Quest Diagnostics, in just a few clicks!

Returns in Quest Diagnostics (DGX) for Indian investors in Rupees

The Quest Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Quest Diagnostics investment value today

Current value as on today

₹1,31,035

Returns

₹31,035

(+31.03%)

Returns from Quest Diagnostics Stock

₹29,567 (+29.57%)

Dollar Returns

₹1,467 (+1.47%)

Indian investors sentiment towards Quest Diagnostics (DGX)

45%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Search interest for Quest Diagnostics Stock from India on INDmoney has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Quest Diagnostics Stock (DGX Ticker)

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	938	1.18	0.04%

Global Institutional Holdings in Quest Diagnostics

Vanguard Group Inc
12.47%
BlackRock Inc
9.04%
T. Rowe Price Associates, Inc.
4.90%
State Street Corp
4.66%
Victory Capital Management Inc.
3.00%
Geode Capital Management, LLC
2.40%

Analyst Recommendation on Quest Diagnostics

Rating

Trend

Hold

40%Buy

59%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Quest Diagnostics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Quest Diagnostics Stock (DGX)

What analysts predicted

Upside of 3.0%

Target:

$183.56

Current:

$178.22

Insights on Quest Diagnostics Stock (Ticker Symbol: DGX)

Price Movement
In the last 3 months, DGX stock has moved up by 9.5%
Increasing Revenue
Revenue is up for the last 6 quarters, 2.28B → 2.65B (in $), with an average increase of 2.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 229.0M → 220.0M (in $), with an average decrease of 1.3% per quarter

Quest Diagnostics Technicals Summary

Sell

Neutral

Buy

Quest Diagnostics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Quest Diagnostics (DGX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Quest Diagnostics Inc.	5.54%	15.34%	29.83%	34.86%	66.46%
Agilent Technologies Inc.	-5.8%	-17.55%	-22.54%	-10.15%	44.09%
Idexx Laboratories, Inc.	4.42%	7.41%	-6.62%	1.07%	59.65%
Thermo Fisher Scientific, Inc.	-11.47%	-21.74%	-25.64%	-21.62%	30.87%
Danaher Corp.	-0.71%	-19.01%	-19.41%	-20.58%	23.49%
Iqvia Holdings Inc.	-10.38%	-25.43%	-34.12%	-29.3%	14.48%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Quest Diagnostics Inc.	22.34	22.34	1.57	9.7	0.14	0.06	0.02	61.87
Agilent Technologies Inc.	24.51	24.51	1.74	5.55	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	40.67	40.67	3.72	11.99	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	24.71	24.71	1.63	22.52	0.14	0.05	0.0	130.57
Danaher Corp.	37.89	37.89	1.94	7.7	0.07	0.04	0.01	71.06
Iqvia Holdings Inc.	20.07	20.07	0.8	11.83	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Quest Diagnostics Inc.	Hold	$20.0B	66.46%	22.34	8.83%
Agilent Technologies Inc.	Buy	$30.7B	44.09%	24.51	19.27%
Idexx Laboratories, Inc.	Buy	$35.5B	59.65%	40.67	22.78%
Thermo Fisher Scientific, Inc.	Buy	$160.0B	30.87%	24.71	15.19%
Danaher Corp.	Buy	$140.2B	23.49%	37.89	15.81%
Iqvia Holdings Inc.	Buy	$26.5B	14.48%	20.07	8.91%

Quest Diagnostics Dividend announcements

Quest Diagnostics Dividends June, 2025
In the quarter ending June,2025. Quest Diagnostics has declared dividend of $0.80

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Organization	Quest Diagnostics
Employees	55000
CEO	Mr. James E. Davis
Industry	Health Services

Management People of Quest Diagnostics

Name	Title
Mr. James E. Davis	Chairman, CEO & President
Mr. Sam A. Samad	Executive VP & CFO
Mr. Michael E. Prevoznik J.D.	Senior VP & General Counsel
Ms. Catherine T. Doherty	Executive Vice President of Regional Businesses
Mr. Karthik Kuppusamy Ph.D.	Senior Vice President of Clinical Solutions
Mr. Michael J. Deppe	Senior VP, Corporate Controller & Chief Accounting Officer
Mr. Murali Balakumar	Senior VP and Chief Information & Digital Officer
Mr. Shawn C. Bevec	Vice President of Investor Relations
Ms. Kristin Lee Wallace Esq.	Senior VP & Chief Compliance Officer
Mr. Garry Clark	Senior VP and Chief Marketing & Communications Officer

Important FAQs about investing in DGX Stock from India :

What is Quest Diagnostics share price today?

Quest Diagnostics share price today stands at $178.22, Open: $177.81 ; Previous Close: $178.50 ; High: $179.00 ; Low: $174.90 ; 52 Week High: $179.00 ; 52 Week Low: $135.27.

The stock opens at $177.81, after a previous close of $178.50. The stock reached a daily high of $179.00 and a low of $174.90, with a 52-week high of $179.00 and a 52-week low of $135.27.

Can Indians buy Quest Diagnostics shares?

Yes, Indians can invest in the Quest Diagnostics (DGX) from India.

With INDmoney, you can buy Quest Diagnostics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Quest Diagnostics at zero transaction cost.

How can I buy Quest Diagnostics shares from India?

It is very easy to buy Quest Diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Quest Diagnostics (DGX) be purchased?

Yes, you can buy fractional shares of Quest Diagnostics with INDmoney app.

What are the documents required to start investing in Quest Diagnostics stocks?

To start investing in Quest Diagnostics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.